Fujirebio Dianostics, Inc.
Fujirebio is a pioneer in the diagnostics industry, focused on developing new technologies and biomarkers with high clinical value. Founded in Japan in 1950, it has a strong tradition of innovating, manufacturing, and marketing high-quality in vitro diagnostics solutions worldwide. The company has expanded its capabilities through acquisitions and collaborates closely with top laboratories to enhance its market offerings. It operates globally with offices in Belgium, France, China, Germany, Italy, Japan, Spain, Sweden, and the United States, among others. The company offers a wide range of products including diagnostic kits, antibodies, genotyping kits, and biomarkers, and provides contract manufacturing and development services.
Industries
Nr. of Employees
Very Large (1000+)
Fujirebio Dianostics, Inc.
2-1-1, Nihonbashi, Chuo-ku, Tokyo 103-0027, Japan
Patents
Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
US-7422848-B2
View Details
Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
US-7422848-B2
View DetailsProducts
Automated immunoassay analyzers (mid-sized)
Mid-sized fully automated immunoassay analyzers designed for clinical laboratory throughput and integration with automated assay kits.
Fully automated immunoassay kits
Assay kits developed for use on automated immunoassay analyzers for quantitative measurement of biomarkers in blood and CSF.
Manual and semi-automated assay kits
Manual and semi-automated formats including line-probe and immunoblot kits for molecular and serological testing.
Controls, calibrators and reagent raw materials
Manufactured controls and calibrators plus antibodies, antigens and other raw reagents for assay production, validation and routine quality control.
Preprogrammed automated test procedures
Instrument protocols for standardized execution of assays on compatible analyzers to reduce operator configuration and improve reproducibility.
Laboratory software for result interpretation and data management
Software tools for reading, interpreting and managing assay data generated by laboratory analyzers, with compatibility for laboratory workflows.
Automated immunoassay analyzers (mid-sized)
Mid-sized fully automated immunoassay analyzers designed for clinical laboratory throughput and integration with automated assay kits.
Fully automated immunoassay kits
Assay kits developed for use on automated immunoassay analyzers for quantitative measurement of biomarkers in blood and CSF.
Manual and semi-automated assay kits
Manual and semi-automated formats including line-probe and immunoblot kits for molecular and serological testing.
Controls, calibrators and reagent raw materials
Manufactured controls and calibrators plus antibodies, antigens and other raw reagents for assay production, validation and routine quality control.
Preprogrammed automated test procedures
Instrument protocols for standardized execution of assays on compatible analyzers to reduce operator configuration and improve reproducibility.
Laboratory software for result interpretation and data management
Software tools for reading, interpreting and managing assay data generated by laboratory analyzers, with compatibility for laboratory workflows.
Services
Contract production and packaging of controls, calibrators, matrix-selected materials and reagents at small and large scale.
Distribution of preprogrammed automated test procedures and laboratory software for standardized execution and interpretation of assays on supported analyzers.
Provision of product regulatory artifacts and support materials to assist with compliance and submissions.
Technical support channels, training materials and troubleshooting resources for product operation and maintenance.
Local subsidiaries and regional offices providing commercial, regulatory and technical interfaces across Europe, Asia and North America.
Contract production and packaging of controls, calibrators, matrix-selected materials and reagents at small and large scale.
Distribution of preprogrammed automated test procedures and laboratory software for standardized execution and interpretation of assays on supported analyzers.
Provision of product regulatory artifacts and support materials to assist with compliance and submissions.
Technical support channels, training materials and troubleshooting resources for product operation and maintenance.
Local subsidiaries and regional offices providing commercial, regulatory and technical interfaces across Europe, Asia and North America.
Expertise Areas
- In-vitro diagnostics (IVD) development
- Immunoassay design and automation
- Biomarker discovery and clinical validation
- Neurodegenerative biomarker assays (CSF and blood)
Key Technologies
- Automated immunoassay analyzers
- Chemiluminescent enzyme immunoassay
- Single-molecule counting and ultrasensitive detection
- Line-probe genotyping assays
News & Updates
Fujirebio announced the acquisition of Plasma Services Group, enhancing its role as a provider of raw materials for the IVD and life sciences sectors.
Highlights from the EUROGIN 2025 conference focusing on HPV-related disease control.
New guidelines for anal cancer screening that expand to broader at-risk groups.
Follow the journey of the Sullivan family and Dr. David Greeley as they introduce new perspectives on Alzheimer's disease.
First blood-based diagnostic test for Alzheimer's disease to receive FDA clearance.
Fujirebio announced the acquisition of Plasma Services Group, enhancing its role as a provider of raw materials for the IVD and life sciences sectors.
Highlights from the EUROGIN 2025 conference focusing on HPV-related disease control.
New guidelines for anal cancer screening that expand to broader at-risk groups.
Follow the journey of the Sullivan family and Dr. David Greeley as they introduce new perspectives on Alzheimer's disease.
First blood-based diagnostic test for Alzheimer's disease to receive FDA clearance.